Free Trial

Health Catalyst (HCAT) News Today

Health Catalyst logo
$3.94 +0.04 (+1.03%)
As of 05/20/2025 04:00 PM Eastern

HCAT Latest News

Health Catalyst, Inc. stock logo
Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Rating of "Moderate Buy" by Analysts
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) has been given a consensus rating of "Moderate Buy" by the ten research firms that are presently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and seven have given a buy recommenda
Health Catalyst, Inc. stock logo
Granahan Investment Management LLC Has $3.49 Million Position in Health Catalyst, Inc. (NASDAQ:HCAT)
Granahan Investment Management LLC trimmed its holdings in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 52.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 493,364 shares of the company's stock af
1 Mooning Stock Worth Your Attention and 2 to Avoid
Health Catalyst, Inc. stock logo
Fred Alger Management LLC Sells 469,644 Shares of Health Catalyst, Inc. (NASDAQ:HCAT)
Fred Alger Management LLC lessened its stake in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 55.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 372,865 shares of the company's stock a
Health Catalyst, Inc. stock logo
Dimensional Fund Advisors LP Increases Stake in Health Catalyst, Inc. (NASDAQ:HCAT)
Dimensional Fund Advisors LP grew its position in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 17.4% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 1,591,565 shares of the company's stock after buying an additional 235,686 shares during the period.
Health Catalyst (NASDAQ:HCAT) Price Target Raised to $5.50
Health Catalyst, Inc. stock logo
Health Catalyst, Inc. (NASDAQ:HCAT) Stock Position Increased by Daventry Group LP
Daventry Group LP lifted its position in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 3.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,509,480 shares of the company's stock after purchasing an add
Health Catalyst, Inc. stock logo
Health Catalyst, Inc. (NASDAQ:HCAT) Shares Purchased by Alyeska Investment Group L.P.
Alyeska Investment Group L.P. raised its holdings in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 74.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,019,380 shares of the company's stock aft
Health Catalyst, Inc. stock logo
Susquehanna Fundamental Investments LLC Buys New Holdings in Health Catalyst, Inc. (NASDAQ:HCAT)
Susquehanna Fundamental Investments LLC purchased a new position in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 114,000 shares of the comp
Health Catalyst, Inc. stock logo
289,117 Shares in Health Catalyst, Inc. (NASDAQ:HCAT) Acquired by Raymond James Financial Inc.
Raymond James Financial Inc. acquired a new stake in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 289,117 shares of the company's stock, valued at ap
Health Catalyst, Inc. stock logo
Health Catalyst (HCAT) Expected to Announce Quarterly Earnings on Wednesday
Health Catalyst (NASDAQ:HCAT) will be releasing its Q1 2025 earnings after the market closes on Wednesday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-7-health-catalyst-inc-stock/)
Health Catalyst, Inc. stock logo
First Light Asset Management LLC Purchases 944,631 Shares of Health Catalyst, Inc. (NASDAQ:HCAT)
First Light Asset Management LLC boosted its position in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 22.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 5,241,121 shares of the company's stock aft
Health Catalyst, Inc. stock logo
Health Catalyst (NASDAQ:HCAT) Given New $6.50 Price Target at Citigroup
Citigroup lowered their price target on Health Catalyst from $7.00 to $6.50 and set a "buy" rating for the company in a research report on Friday.
Health Catalyst price target lowered to $6.50 from $7 at Citi
Health Catalyst, Inc. stock logo
495,945 Shares in Health Catalyst, Inc. (NASDAQ:HCAT) Purchased by Penn Capital Management Company LLC
Penn Capital Management Company LLC purchased a new position in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 495,945 shares of the co
Health Catalyst, Inc. stock logo
Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) have earned an average rating of "Moderate Buy" from the ten analysts that are presently covering the firm, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to
Health Catalyst, Inc. stock logo
KeyCorp Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $5.00
KeyCorp reduced their target price on Health Catalyst from $7.00 to $5.00 and set an "overweight" rating for the company in a report on Wednesday.
Health Catalyst price target lowered to $5 from $7 at KeyBanc
KeyBanc Remains a Buy on Health Catalyst (HCAT)
Health Catalyst, Inc. stock logo
Health Catalyst, Inc. (NASDAQ:HCAT) Stake Lifted by Portolan Capital Management LLC
Portolan Capital Management LLC raised its position in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 12.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 749,029 shares of the company's stock after purcha
Health Catalyst, Inc. stock logo
Vanguard Group Inc. Has $31.07 Million Position in Health Catalyst, Inc. (NASDAQ:HCAT)
Vanguard Group Inc. cut its holdings in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 4.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,394,731 shares of the company's stock after selli
Health Catalyst, Inc. stock logo
Kennedy Capital Management LLC Grows Position in Health Catalyst, Inc. (NASDAQ:HCAT)
Kennedy Capital Management LLC increased its position in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 42.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,891,000 shares of the company's stock after acquiring a
Health Catalyst, Inc. stock logo
Health Catalyst (NASDAQ:HCAT) Lowered to "Inline" Rating by Evercore ISI
Evercore ISI lowered Health Catalyst from an "outperform" rating to an "inline" rating in a report on Wednesday.
Health Catalyst, Inc. stock logo
Health Catalyst's (HCAT) "In-Line" Rating Reiterated at Evercore ISI
Evercore ISI reiterated an "in-line" rating and issued a $4.00 target price (down from $6.00) on shares of Health Catalyst in a research note on Wednesday.
Health Catalyst, Inc. stock logo
Insider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) COO Sells 5,209 Shares of Stock
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) COO Daniel Lesueur sold 5,209 shares of the stock in a transaction that occurred on Thursday, April 3rd. The stock was sold at an average price of $4.15, for a total transaction of $21,617.35. Following the transaction, the chief operating officer now directly owns 211,041 shares in the company, valued at approximately $875,820.15. This represents a 2.41 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Health Catalyst downgraded to In Line from Outperform at Evercore ISI
Health Catalyst, Inc. stock logo
Health Catalyst, Inc. (NASDAQ:HCAT) COO Sells $21,617.35 in Stock
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) COO Daniel Lesueur sold 5,209 shares of the business's stock in a transaction that occurred on Thursday, April 3rd. The stock was sold at an average price of $4.15, for a total value of $21,617.35. Following the completion of the transaction, the chief operating officer now directly owns 211,041 shares in the company, valued at approximately $875,820.15. This represents a 2.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Health Catalyst, Inc. stock logo
Short Interest in Health Catalyst, Inc. (NASDAQ:HCAT) Grows By 24.1%
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 2,940,000 shares, an increase of 24.1% from the February 28th total of 2,370,000 shares. Currently, 5.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 807,300 shares, the days-to-cover ratio is currently 3.6 days.
Health Catalyst, Inc. stock logo
Health Catalyst, Inc. (NASDAQ:HCAT) Shares Sold by Pier 88 Investment Partners LLC
Pier 88 Investment Partners LLC decreased its holdings in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 86.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 170,890 shares of the company's stock after selling 1,052,550 shares during th
Health Catalyst, Inc. stock logo
Palogic Value Management L.P. Takes $2.26 Million Position in Health Catalyst, Inc. (NASDAQ:HCAT)
Palogic Value Management L.P. purchased a new stake in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 320,000 shares of the company's stock, valued at approx
Health Catalyst, Inc. stock logo
Charles Schwab Investment Management Inc. Has $3.52 Million Position in Health Catalyst, Inc. (NASDAQ:HCAT)
Charles Schwab Investment Management Inc. trimmed its stake in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 13.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 497,295 shares of the company's stock after selli
Health Catalyst, Inc. stock logo
Palogic Value Management L.P. Invests $2.26 Million in Health Catalyst, Inc. (NASDAQ:HCAT)
Palogic Value Management L.P. purchased a new position in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 320,000 shares of the company's stock, val
Get Health Catalyst News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter.

HCAT Media Mentions By Week

HCAT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HCAT
News Sentiment

0.46

0.65

Average
Medical
News Sentiment

HCAT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HCAT Articles
This Week

3

4

HCAT Articles
Average Week

Get Health Catalyst News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:HCAT) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners